Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wasif Saif

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Expert Opinion on Drug Safety|December 17, 2009
Platelet count less than SHARP: what does a case series reveal?M Wasif Saif
Clinical Colorectal Cancer|March 4, 2006
Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?M Wasif Saif, Robert Diasio
Expert Opinion on Drug Safety|March 21, 2007
Incidence and management of cutaneous toxicities associated with cetuximabM Wasif Saif, Richard Kim
Therapeutics and Clinical Risk Management|March 25, 2008
Management of oxaliplatin-induced peripheral neuropathyM Wasif Saif, John Reardon
Therapeutic Advances in Gastroenterology|July 2, 2016
Neoadjuvant therapy for pancreatic cancer: an ongoing debateSuzanne Russo, M Wasif Saif
Clinical Advances in Hematology & Oncology : H&O|March 11, 2009
K-ras mutations in colorectal cancer: a practice changing discoveryM Wasif Saif, Manasi Shah
Expert Opinion on Drug Safety|June 16, 2006
Incidence and management of bevacizumab-related toxicities in colorectal cancerM Wasif Saif, Ranee Mehra
Current Opinion in Oncology|November 13, 2014
Pancreatic neuroendocrine tumors: targeting the molecular basis of diseaseSimon Khagi, M Wasif Saif
Nature Reviews. Clinical Oncology|July 6, 2011
Chemotherapy: Metastatic pancreatic cancer--is FOLFIRINOX the new standard?M Wasif Saif, John Chabot
Clinical Colorectal Cancer|June 3, 2005
Edotecarin: a novel topoisomerase I inhibitorM Wasif Saif, Robert B Diasio
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Expert Opinion on Drug Safety|December 17, 2009
Platelet count less than SHARP: what does a case series reveal?M Wasif Saif
Clinical Colorectal Cancer|March 4, 2006
Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?M Wasif Saif, Robert Diasio
Expert Opinion on Drug Safety|March 21, 2007
Incidence and management of cutaneous toxicities associated with cetuximabM Wasif Saif, Richard Kim
Therapeutics and Clinical Risk Management|March 25, 2008
Management of oxaliplatin-induced peripheral neuropathyM Wasif Saif, John Reardon
Therapeutic Advances in Gastroenterology|July 2, 2016
Neoadjuvant therapy for pancreatic cancer: an ongoing debateSuzanne Russo, M Wasif Saif
Clinical Advances in Hematology & Oncology : H&O|March 11, 2009
K-ras mutations in colorectal cancer: a practice changing discoveryM Wasif Saif, Manasi Shah
Expert Opinion on Drug Safety|June 16, 2006
Incidence and management of bevacizumab-related toxicities in colorectal cancerM Wasif Saif, Ranee Mehra
Current Opinion in Oncology|November 13, 2014
Pancreatic neuroendocrine tumors: targeting the molecular basis of diseaseSimon Khagi, M Wasif Saif
Nature Reviews. Clinical Oncology|July 6, 2011
Chemotherapy: Metastatic pancreatic cancer--is FOLFIRINOX the new standard?M Wasif Saif, John Chabot
Clinical Colorectal Cancer|June 3, 2005
Edotecarin: a novel topoisomerase I inhibitorM Wasif Saif, Robert B Diasio
Pageof 9